Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings

@article{Hashimoto2019RecentAI,
  title={Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings},
  author={Kenji Hashimoto},
  journal={Current Psychiatry Reports},
  year={2019},
  volume={21},
  pages={1-9}
}
  • K. Hashimoto
  • Published 2019
  • Medicine
  • Current Psychiatry Reports
Purpose of ReviewIn the past decade, there has been increasing interest in the potential benefit of early intervention in schizophrenia. Patients with schizophrenia show cognitive impairment for several years preceding the onset of psychosis. The author discusses the recent topics on prevention of schizophrenia.Recent FindingsPreclinical findings suggest that maternal immune activation (MIA) produces cognitive deficits as a prodromal symptom in juvenile offspring in rodents. Treatment with anti… Expand
D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
TLDR
Preclinical and clinical studies with D-serine indicate that it may be effective in reducing cognitive dysfunction and may be a biomarker for antidepressant response to ketamine. Expand
Prediction of the significance in the improvement of depression symptoms of amisulpride in the treatment of schizophrenia: an 8-week case-control study.
TLDR
Amisulpride is effective in the treatment of schizophrenia and improving depression symptoms, and the improvement of depression symptoms has no significant predictive effect on the remission of schizophrenia symptoms. Expand
The influence of immune activation at early vs late gestation on fetal NRG1-ErbB4 expression and behavior in juvenile and adult mice offspring
TLDR
The results suggest that MIA during late gestation immediately influences the expression levels of the NRG1 and ErbB4 genes, and affects long-term behavioral changes at adulthood, which are time related and sex-specific. Expand
Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia
TLDR
The role and mutual interactions of oxidative damage and impaired glucose metabolism as key factors affecting metabolic complications in schizophrenia are summarized to provide a premise for novel potential therapeutic targets that will delay not only the onset of first symptoms but also the progression of schizophrenia and its complications. Expand
Omega-3 Polyunsaturated Fatty Acid Deficiency and Progressive Neuropathology in Psychiatric Disorders: A Review of Translational Evidence and Candidate Mechanisms
TLDR
Meta-analytic evidence indicates that mood and psychotic disorders are associated with both omega-3 polyunsaturated fatty acid (omega-3 PUFA) deficits and progressive regional gray and white matter pathology, and evidence from translational research suggests that omega- 3 PUFA insufficiency may represent a plausible and modifiable risk factor for enduring neurodevelopmental abnormalities in brain structure and function. Expand
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
TLDR
Clinical and preclinical studies on schizophrenia and ASD investigating the behavioral, molecular, and functional effects of chronic treatment with CBD (and with cannabidivarin for ASD) during neurodevelopment point to CBD's beneficial potential for the progression of these disorders supporting further investigations to strengthen its use. Expand
The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting
TLDR
The role of Nrf2 pathway and its modulators in psychiatric disorders is explored to find immense potential opportunities for these modulators to become a novel therapeutic option. Expand
Dietary intake of glucoraphanin during pregnancy and lactation prevents the behavioral abnormalities in the offspring after maternal immune activation
TLDR
Whether dietary intake of glucoraphanin (GF: the precursor of a natural anti‐inflammatory compound sulforaphane) can prevent the onset of behavioral abnormalities in offspring after MIA is examined. Expand
Increased expression of soluble epoxide hydrolase in the brain and liver from patients with major psychiatric disorders: A role of brain - liver axis.
TLDR
This study shows that the increased expression of sEH in the brain and liver might play a role in the pathogenesis of major psychiatric disorders, suggesting a role of brain - liver axis in major Psychiatric disorders. Expand
Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders
TLDR
It is argued that oxidative stress may be a good target for future pharmacotherapy in schizophrenia and a multi-step model of illness progression with oxidative stress involved at each stage is suggested. Expand
...
1
2
...

References

SHOWING 1-10 OF 96 REFERENCES
Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activation
TLDR
This study shows that supplementing offspring with D-serine during juvenile and adolescent stages could prevent the onset of psychosis in adulthood, after MIA, and therefore, early intervention in high-risk subjects may prevent the occurrence of psychosis. Expand
Intake of 7,8-Dihydroxyflavone During Juvenile and Adolescent Stages Prevents Onset of Psychosis in Adult Offspring After Maternal Immune Activation
TLDR
It is found that the juvenile offspring of poly(I:C)-treated mice showed cognitive deficits, as well as reduced BDNF-TrkB signaling in the prefrontal cortex (PFC), and intervention by a TrkB agonist in subjects with ultra-high risk for psychosis may reduce the risk of subsequent transition to schizophrenia. Expand
D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
TLDR
Preclinical and clinical studies with D-serine indicate that it may be effective in reducing cognitive dysfunction and may be a biomarker for antidepressant response to ketamine. Expand
Microglial activation and progressive brain changes in schizophrenia
TLDR
Evidence for microglial dysfunction in schizophrenia is reviewed from both neuroimaging and neuropathological data, with a specific focus on studies examining microglia activation in relation to the pathology of grey and white matter. Expand
Increased Levels of C1q in the Prefrontal Cortex of Adult Offspring after Maternal Immune Activation: Prevention by 7,8-Dihydroxyflavone
  • Mei Han, Ji-chun Zhang, K. Hashimoto
  • Medicine
  • Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
  • 2017
TLDR
It is likely that increased C1q expression in the frontal cortex may play a role in the behavioral abnormalities of adult offspring after MIA and supplementation with a TrkB agonist such as 7,8-DHF during the prodromal stage may have prophylactic effects on the behavior abnormalities after MIA. Expand
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia
TLDR
The patient cohorts in this study do not substantiate the assumption of microglial activation in schizophrenia as a regular and defining feature, as measured by 11C-(R)-PK11195 BPND, and no correlations with regional gray matter, peripheral cytokine levels or clinical symptoms were detected. Expand
Targeting of NMDA receptors in new treatments for schizophrenia
  • K. Hashimoto
  • Biology, Medicine
  • Expert opinion on therapeutic targets
  • 2014
TLDR
Given the NMDA receptor hypothesis of schizophrenia, the glycine modulatory site on NMDA receptors is the most attractive therapeutic target for this disease, and both the kynurenine pathway and cystine-glutamate antiporter represent credible potential therapeutic targets for schizophrenia. Expand
Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
TLDR
Results overall support suggest that MMN may have negative, as well as positive, predictive value in predicting efficacy of novel compounds, and are consistent with meta-analyses showing significant effects of d-serine in schizophrenia. Expand
Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation
TLDR
It is demonstrated that dietary intake of glucoraphanin (GF), the precursor of a natural antioxidant sulforaphane, during juvenile and adolescent stages prevented cognitive deficits and loss of parvalbumin (PV) immunoreactivity in the medial prefrontal cortex of adult offspring after MIA. Expand
Schizophrenia: Basic and Clinical.
  • J. Coyle
  • Medicine
  • Advances in neurobiology
  • 2017
TLDR
Pharmacologic challenge studies, postmortem analyses and a recent sufficiently powered genome-wide association study and copy number variant studies provide compelling evidence that NMDA receptor hypofunction is an important pathophsysiologic feature of schizophrenia. Expand
...
1
2
3
4
5
...